Adenoviral Conjunctivitis: Comprehensive Academic

Garcia-Zalisnak D, Rapuano C, Sheppard JD, Davis AR. Adenovirus ocular infections: prevalence, pathology, pitfalls, and practical pointers. Eye Contact Lens. 2018;44 Suppl 1:S1-S7. doi:10.1097/ICL.0000000000000226.

Jhanji V, Chan TCY, Li EYM, Agarwal K, Vajpayee RB. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60(5):435-443. doi:10.1016/j.survophthal.2015.04.001.

Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology. 2017;124(8):1099-1107. doi:10.1016/j.ophtha.2017.03.021.

Kuo IC, Espinosa C, Forman M, Valsamakis A. A PCR-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees. Am J Ophthalmol. 2016;163:38-44. doi:10.1016/j.ajo.2015.12.007.

Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis. 1993;167(6):1307-1313. doi:10.1093/infdis/167.6.1307.

Aoki K, Tagawa Y. A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan. Jpn J Ophthalmol. 2002;46(5):491-497. doi:10.1016/S0021-5155(02)00523-5.

Jin XH, Aoki K, Kitaichi N, et al. Genome variability of human adenovirus type 8 causing epidemic keratoconjunctivitis during 1986–2003 in Japan. Mol Vis. 2011;17:3121-3127. PMID: 22171162.

Fujimoto T, Matsushima Y, Shimizu H, et al. Molecular epidemiology of human adenovirus type 8 causing EKC in Kawasaki, Japan, 2011. Jpn J Infect Dis. 2012;65(3):260-263. doi:10.7883/yoken.65.260.

Kowalski RP, Romanowski EG, Waikhom B, et al. The survival of adenovirus in multidose bottles of topical fluorescein. Am J Ophthalmol. 1998;126(5):835-836. doi:10.1016/S0002-9394(98)00248-6.

Dawson CR, Hanna L, Wood TR, Despain R. Adenovirus type 8 keratoconjunctivitis in the United States. Am J Ophthalmol. 1970;69(3):473-480. doi:10.1016/0002-9394(70)90156-5.

Adams CP Jr, Cohen EJ, Albrecht J, et al. Interferon treatment of adenoviral conjunctivitis. Am J Ophthalmol. 1984;98(4):429-432. doi:10.1016/0002-9394(84)90100-3.

Karaca EE, Aynaci ZN, Kemer OE. Complication management in adenoviral keratoconjunctivitis: review. J Glau-Cat. 2023;18(3):99-105. doi:10.37844/glau.cat.2023.18.14.

Laibson PR, Dhiri S, Oconer J, et al. Corneal infiltrates in EKC: response to corticosteroid therapy. Arch Ophthalmol. 1970;84(1):36-40. doi:10.1001/archopht.1970.00990010038008.

Laibson PR, Green WR. Conjunctival membranes in EKC. Arch Ophthalmol. 1970;83(1):100-102. doi:10.1001/archopht.1970.00990020102014.

Levinger E, Slomovic A, Sansanayudh W, et al. Topical cyclosporine for SEIs in adenoviral keratoconjunctivitis. Cornea. 2010;29(6):638-640. doi:10.1097/ICO.0b013e3181c2956c.

Saitoh-Inagawa W, Oshima A, Aoki K. Rapid diagnosis of adenoviral conjunctivitis by PCR. J Clin Microbiol. 1996;34(9):2113-2116. doi:10.1128/jcm.34.9.2113-2116.1996.

Artieda J, Pineiro L, Gonzalez M, et al. Swimming pool–related outbreak of PCF due to adenovirus type 4, Spain. Euro Surveill. 2009;14(8):19125. PMID:19280117.

Kuo SC, Shen SC, Chang SW, et al. Corneal superinfection in acute viral conjunctivitis in children. J Pediatr Ophthalmol Strabismus. 2008;45(6):374-376. doi:10.3928/01913913-20081101-09.

Kim SI, Lee KW. Orbital inflammation from EKC in adults. Case Rep Ophthalmol. 2013;4(2):93-98. doi:10.1159/000351648.

Kay KM, Woo KI, Kim JH, et al. Acquired nasolacrimal duct obstruction in children. Jpn J Ophthalmol. 2007;51(6):437-441. doi:10.1007/s10384-007-0473-7.

Ozturk H, Sonmez B, Beden U, et al. Corneal sensitivity decrease in adenoviral EKC. Eye Contact Lens. 2013;39(4):264-268. doi:10.1097/ICL.0b013e3182871065.

Liu SH, Hawkins BS, Ng SM, et al. Pharmacologic interventions for EKC: Cochrane review. Cochrane Database Syst Rev. 2022;3:CD015126. doi:10.1002/14651858.CD015126.

Yang S, Rothman RE. PCR diagnostics for infectious diseases. Lancet Infect Dis. 2004;4(6):337-348. doi:10.1016/S1473-3099(04)01044-8.

Sambursky R, Trattler W, Tauber S, et al. Sensitivity/specificity of AdenoPlus. JAMA Ophthalmol. 2013;131(1):17-22. doi:10.1001/jamaophthalmol.2013.566.

Shunmugam M, Giovannetti F, Yeung SN, Iovieno A. Update on viral conjunctivitis treatment. Microorganisms. 2025;13(8):1712. doi:10.3390/microorganisms13081712.

Chintakuntlawar AV, Chodosh J. Architecture of conjunctival membranes in EKC. Ocul Immunol Inflamm. 2010;18(5):341-345. doi:10.3109/09273948.2010.486053.

Butt AL, Chodosh J. Adenoviral keratoconjunctivitis in tertiary clinics. Cornea. 2006;25(2):199-202. doi:10.1097/01.ico.0000191570.14360.53.

Laibson PR, Dhiri S, Oconer J, et al. Corticosteroid therapy in EKC. Arch Ophthalmol. 1970;84(1):36-40. doi:10.1001/archopht.1970.00990010038008.

Hillenkamp J, Reinhard T, Ross RS, et al. Topical cidofovir and cyclosporine for acute EKC. Arch Ophthalmol. 2001;119(10):1487-1491. doi:10.1001/archopht.119.10.1487.

Tabbara KF, Jarade E. Ganciclovir effects in adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2001;42(4):S579.

Adams CP Jr, Cohen EJ, Albrecht J, et al. Interferon treatment of adenoviral conjunctivitis. Am J Ophthalmol. 1984;98(4):429-432.

Yates KA, Shanks RMQ, Kowalski RP, Romanowski EG. Povidone–iodine evaluation vs adenovirus. J Ocul Pharmacol Ther. 2019;35(2):132-136. doi:10.1089/jop.2018.0127.

Than T, Morettin CE, Harthan JS, et al. Efficacy of 5% PVP-I single dose. Am J Ophthalmol. 2021;231:28-38. doi:10.1016/j.ajo.2021.05.005.

Soleimani M, Haydar AA, Cheraqpour K, et al. PVP-I application in ophthalmology. Surv Ophthalmol. 2024;69(2):211-223. doi:10.1016/j.survophthal.2023.05.006.

Hadad R, Hedengran A, Barnils A, et al. Antiseptic effects on conjunctival goblet cells. Acta Ophthalmol. 2024;102(8):773-778. doi:10.1111/aos.15745.

Gottsch JD. Surveillance and control of EKC. Trans Am Ophthalmol Soc. 1996;94:539-587. PMID:8981704.

Dart JK, El-Amir AN, Maddison T, et al. Control of nosocomial adenoviral EKC in UK. Br J Ophthalmol. 2009;93(1):18-20. doi:10.1136/bjo.2008.142182.

Paparello SF, Rickman LS, Mesbahi HN, et al. EKC outbreak in US military base. Mil Med. 1991;156(5):256-259. doi:10.1093/milmed/156.5.256.

Piednoir E, Bureau-Chalot F, Merle C, et al. Costs of nosocomial adenoviral conjunctivitis. Am J Infect Control. 2002;30(7):407-410. doi:10.1067/mic.2002.124201.